세계호흡기질환치료제시장 2018-2022 ■ 영문명 : Global Respiratory Drugs Market 2018-2022
■ 상품코드 : IRTNTR21841 ■ 조사/발행사 : Technavio■ 발행일 : 2018년 11월 12일 ■ 쪽수 : 113 ■ 작성언어 : 영어 ■ 보고서형태 : PDF ■ 납품방식 : 이메일 ■ 조사대상지역 : 글로벌, 미주, 유럽, 아시아 ■
본 조사보고서는 호흡기 질환 치료제의 세계 시장에 대해 조사 분석한 자료로서 호흡기 질환 치료제의 세계시장 규모, 시장 동향, 시장 환경 분석, 세그먼트별 분석, 지역별 분석(미주, 유럽, 아시아), 관련 기업 정보 등을 포함하고 있습니다.
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 04: MARKET LANDSCAPE• Market ecosystem• Market characteristics• Market segmentation analysisPART 05: PIPELINE ANALYSIS• Pipeline analysisPART 06: MARKET SIZING• Market definition• Market sizing 2017• Market size and forecast 2017-2022PART 07: FIVE FORCES ANALYSIS• Bargaining power of buyers• Bargaining power of suppliers• Threat of new entrants• Threat of substitutes• Threat of rivalry• Market conditionPART 08: MARKET SEGMENTATION BY TYPE OF RESPIRATORY DISEASE• Segmentation by type of respiratory disease• Comparison by type of respiratory disease• Asthma – Market size and forecast 2017-2022• COPD – Market size and forecast 2017-2022• Allergic rhinitis – Market size and forecast 2017-2022• Cystic fibrosis – Market size and forecast 2017-2022• Idiopathic pulmonary fibrosis – Market size and forecast 2017-2022• Other respiratory disorders – Market size and forecast 2017-2022• Market opportunity by type of respiratory diseasePART 09: CUSTOMER LANDSCAPEPART 10: REGIONAL LANDSCAPE• Geographical segmentation• Regional comparison• Americas – Market size and forecast 2017-2022• EMEA – Market size and forecast 2017-2022• APAC – Market size and forecast 2017-2022• Market opportunityPART 11: DECISION FRAMEWORKPART 12: DRIVERS AND CHALLENGES• Market drivers• Market challengesPART 13: MARKET TRENDS• High cost of respiratory disease management• Availability of biologics and biosimilars• High use of complementary and alternative medicines• Entry of genericsPART 14: VENDOR LANDSCAPE• Overview• Landscape disruptionPART 15 : VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • AstraZeneca • GlaxoSmithKline • Merck • NovartisPART 16 : APPENDIX • List of abbreviations
[세계호흡기질환 치료제 시장 2018-2022]에 대한 자세한 내용은 아래 링크를 참조하여 보고서 개요 및 구입방법 등을 확인하실 수 있습니다.
https://www.globalresearch.co.kr/report/global-respiratory-drugs-market-irtntr21841111 pages, November 2018About this market The high cost of respiratory disease management is expected to drive growth in the respiratory drugs market. The high cost of respiratory disease management has led the organizations such as the Lung Foundation Australia to demand support and funding from th…www.globalresearch.co.kr
